CN Stock MarketDetailed Quotes

002821 Asymchem Laboratories

Watchlist
  • 63.88
  • +0.30+0.47%
Market Closed Sep 13 15:00 CST
23.49BMarket Cap21.72P/E (TTM)

About Asymchem Laboratories Company

The company is a world-leading CDMO company that provides one-stop services for high-quality R&D and production of global new drugs. With the mission of speeding up the launch of new drugs and extending the quality of life, we rely on continuous technological innovation to provide one-stop CMC services for domestic and foreign pharmaceutical companies and biotechnology companies throughout the drug life cycle, and accelerate the development and application of new drugs. The company actively explores and lays out emerging business segments such as chemical macromolecule CDMO, pharmaceutical CDMO, clinical CRO, biomacromolecule CDMO, technology export and synthetic biotechnology, making the company a professional one-stop customized service platform for all-round innovative drugs. The main products are small molecule CDMO services, chemical macromolecule CDMO business segment, pharmaceutical CDMO business segment, clinical CRO business segment, biomacromolecule CDMO business segment, technology export business segment, and synthetic biotechnology business segment. In 2019, the company won the “2018 Best Partner for the Transformation and Upgrading of Chinese Pharmaceutical Enterprises”. A total of 6 award-winning companies/organizations were selected in this selection. As the only pharmaceutical CDMO company on the list, the company received awards through various levels of screening with excellent quality and service, good reputation and reputation — this is also another time for the company to win this award. It won two awards, “China's Top 100 Pharmaceutical Industry” and “China's Top 20 Pharmaceutical Outsourcing Companies” in the “2018 China Pharmaceutical Industry Most Influential List” issued by the Pharmaceutical Industry Chamber of Commerce of the All-China Federation of Industry and Commerce, fully demonstrating the company's strong competitiveness and strong growth as an industry benchmark.

Company Profile

Short Name-A凯莱英
Symbol-A002821
Short Name-H凯莱英
Symbol-H06821
Company NameAsymchem Laboratories (Tianjin) Co., Ltd.
Listing DateNov 18, 2016
Issue Price30.53
Shares Offered28.22M share(s)
FoundedOct 7, 1998
Listed ExchangeSZ Stock Exchange
Legal RepresentativeHAO HONG
General ManagerHAO HONG
Secretaryxiangke xu
Accounting FirmErnst & Young (Special General Partnership)
Securities Representativezhangliang yu
Legal CounselBeijing Deheng Law Firm
Employees9300
Phone022-66389560
Office AddressNo. 71 Seventh Street, Tianjin Economic and Technological Development Zone
Zip Code300457
Registered AddressNo. 6, Dongting 3rd Street, Tianjin Economic and Technological Development Zone
Fax022-66252777
Emailsecurities@asymchem.com.cn
Business License120000400035153
BusinessDevelop, produce and sell high-tech pharmaceutical raw materials and intermediates and biotechnology products, formulation research and development, import and export of related equipment and accessories, wholesale and retail business (no stores), and related technical consulting services and technology transfer.

Company Executives

  • Name
  • Position
  • Salary
  • HAO HONG
  • Chairman, directors, general manager, Chief Executive Officer (CEO), Strategy Committee Convener
  • 6.10M
  • YE SONG
  • Directors
  • 702.80K
  • ting zhang
  • Directors, Audit Committee Member
  • 1.57M
  • da zhang
  • directors, Deputy General Manager, Chief Financial Officer (CFO), Member of the Remuneration and Assessment Committee, Chief Operating Officer (COO)
  • 5.45M
  • rui yang
  • Directors, Deputy General Manager, Co-CEO, Member of the Strategy Committee
  • 6.47M
  • liang hong
  • Directors, Nomination Committee Members, Executive Vice President
  • 3.93M
  • xinyi hou
  • Independent Directors, Nomination Committee Members, Remuneration and Assessment Committee Convener, Audit Committee Member
  • --
  • xuejiao sun
  • Independent Directors, Audit Committee Convener, Member of the Remuneration and Assessment Committee
  • 37.50K
  • jiacong li
  • Independent Directors, Member of the Strategy Committee, Nomination Committee Convener
  • 150.00K
  • xiangke xu
  • Board Secretary, VP
  • 1.93M
  • zhangliang yu
  • Securities Affairs Representative
  • --
  • xinxin zhi
  • Chairman of the Supervisory Board, Shareholder Supervisors
  • 374.90K
  • shanshan di
  • Shareholder Supervisors
  • 194.40K
  • James Randolph Gage
  • Deputy General Manager
  • 1.67M
  • yan zhou
  • VP
  • 2.01M
  • yi xiao
  • Senior Vice President
  • 3.10M
  • XINHUI HU
  • Chief Technology Officer (CTO)
  • 7.72M
  • jingyi hou
  • Employee Supervisors
  • 430.70K
  • yingwei jiang
  • Executive Vice President
  • 3.42M
  • chaoyong chen
  • Executive Vice President
  • 4.22M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data